Advancing New Standards in Reproductive Health and Cambridge Reproductive Health Consultants

Investment Type: Grant
Year: 2019, 2020, 2021
Amount: $575,000
Organization Types: Nonprofits

Advancing New Standards in Reproductive Health (ANSIRH) is a collaborative research group at the University of California, San Francisco (UCSF)’s Bixby Center for Global Reproductive Health. They conduct innovative, rigorous, multidisciplinary research on complex issues related to people’s sexual and reproductive lives. Their work is informed by an understanding of the role that structural inequities play in shaping health. They believe in the importance of research in advancing evidence-based policy, practice, and public discourse to improve reproductive wellbeing.

Cambridge Reproductive Health Consultants (CRHC) is a non-profit organization which improves reproductive health and fosters reproductive justice worldwide. By leveraging the skills of professionals from a variety of fields and disciplines, CRHC increases access to safe, legal, high quality, and affordable abortion care, reduces harm from unsafe abortion, increases access to emergency contraception and long-acting reversible contraceptive methods, and advances new reproductive health technologies in low resource environments and protracted refugee and conflict settings. CRHC accomplishes its mission by conducting action- and intervention-oriented research, creating and incubating new and innovative programs, and delivering evidence-based reproductive health information, resources, and trainings.

Why we invest:

Tara Health provided a three-year restricted grant to ANSIRH and CRHC to jointly study, test and investigate current and new menstrual regulation frames in the US context.

ANSIRH’s aspect of the project involves their undertaking of a proof of concept study for a “Missed Period Pill” using misoprostol to test the framework of menstrual regulation to “bring back” or “bring down” a period after it is missed. This study will evaluate feasibility and acceptability for a potential new fertility intervention to be utilized before a person confirms they are pregnant – a method that could fill an important need where reproductive autonomy is under assault.

For their part of the study, CRHC will undertake multi-methods, qualitative research that explores the resonance of new frameworks for the early use of uterine evacuation medicines (i.e. missed period pills, menstrual regulation, or bringing down a period). Their project will focus on women of reproductive age, health service providers, and reproductive health and justice advocates in the US. It will include outreach to and participation with reproductive health and justice organizations to explain, discuss, and build support for new frames and pilot projects in this liminal space so as to move forward with underlying support from key stakeholders.

< Return to Portfolio